Inge C.F.M. Roozen

Phase I dose-escalation study of the protein kinase C (PKC) inhibitor AEB071 in patients with metastatic uveal melanoma.

Sophie Piperno‐Neumann, Ellen Kapiteijn, James Larkin et al. · Journal of Clinical Oncology · 2014 · 54 citations

Immunology, Immunotherapeutics, Dermatology +17

Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions

Frank M. Speetjens, Marij J.P. Welters, Marije Slingerland et al. · Journal for ImmunoTherapy of Cancer · 2022 · 31 citations · Full text

Low-dose interferon-alpha preconditioning and adoptive cell therapy in patients with metastatic melanoma refractory to standard (immune) therapies: a phase I/II study

Els M.E. Verdegaal, Monique K. van der Kooij, Marten Visser et al. · Journal for ImmunoTherapy of Cancer · 2020 · 26 citations · Full text

Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer

Els M.E. Verdegaal, Saskia J. Santegoets, Marij J.P. Welters et al. · Journal for ImmunoTherapy of Cancer · 2023 · 25 citations · Full text

Landscape of genetic alterations in patients with metastatic uveal melanoma.

Sophie Piperno‐Neumann, Ellen Kapiteijn, James Larkin et al. · Journal of Clinical Oncology · 2014 · 17 citations

Pathology, Dermatology, Tumor Biology +19